Ensembles of Multiple Models and Architectures for Robust Brain Tumour Segmentation

Abstract: Deep learning approaches such as convolutional neural nets have consistently outperformed previous methods on challenging tasks such as dense, semantic segmentation. However, the various proposed networks perform differently, with behaviour largely influenced by architectural choices and training settings. This paper explores Ensembles of Multiple Models and Architectures (EMMA) for robust performance through aggregation of predictions from a wide range of methods. The approach reduces the influence of the meta-parameters of individual models and the risk of overfitting the configuration to a particular database. EMMA can be seen as an unbiased, generic deep learning model which is shown to yield excellent performance, winning the first position in the BRATS 2017 competition among 50+ participating teams.

• The paper demonstrates that ensembling diverse CNN architectures mitigates meta-parameter bias for robust brain tumor segmentation.
• The EMMA methodology integrates DeepMedic, FCNs, and U-Nets with varied configurations to achieve consistent performance in the BRATS 2017 challenge.
• The results highlight superior segmentation accuracy and model invariance, paving the way for reliable clinical applications and future research.

An Essay on "Ensembles of Multiple Models and Architectures for Robust Brain Tumour Segmentation"

The paper "Ensembles of Multiple Models and Architectures for Robust Brain Tumour Segmentation" addresses the challenge of brain tumor segmentation through an innovative method in ensemble learning. The research demonstrates the efficacy of using an ensemble of multiple models, defined as EMMA, to mitigate the impact of meta-parameter biases inherent in individual deep learning models. By combining a diverse set of deep neural network architectures, this methodology enhances the robustness and objectivity of brain tumor segmentation, as evidenced by its superior performance in the BRATS 2017 competition.

Motivation and Background

Brain tumors, specifically gliomas, pose significant diagnostic and treatment challenges due to their aggressive nature and complex morphology. As gliomas exhibit differing appearances across various neuro-imaging modalities, manual segmentation is both time-intensive and prone to variability among observers. This necessitates automated systems capable of providing reliable and consistent segmentation.

Traditional methods employing machine learning have shown promise. However, the introduction of convolutional neural networks (CNNs) significantly improved segmentation capabilities. Despite their advantages, CNNs are sensitive to configuration choices, which can lead to models being overfit to specific datasets. The proposed EMMA system aims to address these issues by utilizing a heterogeneous ensemble approach.

Methodology

The authors of this paper present an ensemble strategy that integrates models with varying CNN architectures and configurations. Key architectures included in EMMA are DeepMedic, FCNs, and U-Nets, each trained using different strategies to promote model diversity. For instance, model variations involve differences in depth, filter numbers, multi-scale context processing, loss functions, optimization techniques, and normalization procedures.

The ensemble strategy in EMMA utilizes a probabilistic perspective where the bias of individual model configurations is marginalized out through averaging. This approach not only stabilizes model performances under various conditions but also provides an invariant model behavior, facilitating objective analysis across different datasets and tasks.

Results

EMMA demonstrated its robustness by achieving the highest ranks in the BRATS 2017 challenge, successfully outperforming numerous teams based on Dice score and Hausdorff distance metrics. Notably, the ensemble's performance remained consistent on both validation and testing datasets, which comprised data from multiple sources. These outcomes showcase EMMA's potential in providing reliable brain tumor segmentation even when faced with dataset heterogeneity.

Implications and Future Work

The implications of EMMA's approach are significant for clinical applications where reliability and precision are critical. By proving its reusability across varying tasks and its potential for application in unbiased analyses, EMMA sets a foundation for further research in ensemble learning within biomedical imaging. Future investigations could explore its application to domain adaptation challenges or extend its use to quantify training data requirements and model uncertainties in other complex domains.

Conclusion

The paper delivers a substantial contribution to the field of medical image analysis by proposing a strategic ensemble methodology that addresses variability and overfitting issues common in deep learning models. By employing a multi-model architecture approach, EMMA ensures robust performance, offering valuable insights for future advancements in both theoretical research and practical applications within biomedical imaging.